Last reviewed · How we verify
NCT05164367
Pharmacokinetics of Atropine Oral Gel
EARLY_PHASE1 trial testing Atropine sulfate gel (0.01%) in Cerebral Palsy in 10 participants. Completed in 10 December 2024.
30 June 2023
Quick facts
| Lead sponsor | University of Utah |
|---|---|
| Phase | EARLY_PHASE1 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 10 |
| Start date | 1 October 2022 |
| Primary completion | 30 June 2023 |
| Estimated completion | 10 December 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Atropine sulfate gel (0.01%)
Conditions studied
- Cerebral Palsy — all drugs for Cerebral Palsy →
- Sialorrhea — all drugs for Sialorrhea →
Sponsor
University of Utah
Who can join
Adults 18 to 50, any sex, with Cerebral Palsy or Sialorrhea. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To evaluate the single-dose pharmacokinetics of atropine gel formulation after topical administration in the oral cavity of healthy adults.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Clinical pharmacokinetics of atropine oral gel formulation in healthy volunteers.
Parrot M, Yathavan B, Averin O, Hoggard L, et al · · 2024 · cited 3× · PMID 38465519 · DOI 10.1111/cts.13753
Verify or expand the search:
- PubMed search for NCT05164367
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cerebral Palsy
Currently open trials in the same condition.
- NCT07524972 — Antenatal Magnesium Sulphate in High-Risk Preterm Patients · Phase 3 · recruiting
- NCT07432789 — Metrological Properties of a Digital Motion Analysis Research Application for Assessing the Motor Abilities and Performa · NA · recruiting
- NCT07466914 — Constipation in Children With Cerebral Palsy · active not recruiting
- NCT05901259 — The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes · recruiting
- NCT07342348 — Using Power Mobility Training to Promote Arm & Hand Function in Children With Cerebral Palsy · NA · recruiting
Other University of Utah trials
Trials by the same sponsor.
- NCT07515755 — Supplemental Oxygen and Oxygen Desaturations in Colonoscopies · NA · not yet recruiting
- NCT07225426 — Personalizing Financial Incentives · NA · recruiting
- NCT06716411 — Confirming the Effects of Acupuncture Treatments to Relieve Symptoms of Gulf War Illness · NA · recruiting
- NCT07246538 — Positive Airway Pressure (PAP) System Evaluation in Volunteers · NA · not yet recruiting
- NCT04208984 — Diversion Device With Breath Control · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05164367 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Utah
- Last refreshed: 18 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05164367.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing